- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01239914
CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT) (COACT)
September 2, 2022 updated by: Kiyuk Chang, MD,PhD, The Catholic University of Korea
COACT registry is a multicenter registry of consecutive patients undergoing coronary stent implantation at 8 centers in the Catholic University of Korea to evaluate the real world management of patients with coronary artery disease and to assess their in-hospital, medium and long-term outcomes.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
11719
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Daejeon, Korea, Republic of
- Daejeon St.Mary's Hospital
-
Incheon, Korea, Republic of
- Incheon St.Mary's Hospital
-
Seoul, Korea, Republic of, 137-701
- Seoul St.Mary's Hospital
-
Seoul, Korea, Republic of
- St.Paul's Hospital
-
Seoul, Korea, Republic of
- Yeouido St.Mary Hospital
-
-
Gyeonggido
-
Bucheon, Gyeonggido, Korea, Republic of
- Bucheon St.Mary Hospital
-
Suwon, Gyeonggido, Korea, Republic of
- St.Vincent's Hospital
-
Uijeongbu, Gyeonggido, Korea, Republic of
- Uijeongbu St.Mary's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
all comers who admitted cardiovascular center for coronary stent implantation
Description
Inclusion Criteria:
- all consecutive patients who underwent percutaneous coronary intervention
- written informed consent for the DNA and serum databank
Exclusion Criteria:
- patients who did not agreed to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
All causes mortality
Time Frame: 6month, each year
|
6month, each year
|
Cardiac death
Time Frame: 6 month, each year
|
6 month, each year
|
Myocardial infarction
Time Frame: 6 month, each year
|
6 month, each year
|
target lesion revascularization
Time Frame: 6 month, each year
|
6 month, each year
|
target vessel revascularization
Time Frame: 6 month, each year
|
6 month, each year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
non target vessel revascularization
Time Frame: 6 month, each year
|
6 month, each year
|
Stent thrombosis
Time Frame: 6 month, each year
|
6 month, each year
|
Serum databank for evaluation of biomarkers outcomes
Time Frame: 6 month, each year
|
6 month, each year
|
Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes
Time Frame: 6 month, each year
|
6 month, each year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Ki-Bae Seung, M.D.,PhD, Seoul st. mary's hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2005
Primary Completion (ACTUAL)
December 1, 2019
Study Completion (ACTUAL)
December 1, 2019
Study Registration Dates
First Submitted
November 12, 2010
First Submitted That Met QC Criteria
November 12, 2010
First Posted (ESTIMATE)
November 15, 2010
Study Record Updates
Last Update Posted (ACTUAL)
September 7, 2022
Last Update Submitted That Met QC Criteria
September 2, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- COACT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina